Sophie de Carné Trécesson

8PUBLICATIONS
90CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 22, 2026
Targeting KRAS codon 13 mutations using direct combination approaches in non-small cell lung cancer.

|Jun 08, 2026
KRAS Inhibitor Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant Subclones.

|Jan 09, 2025
Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma.

Dhruva Biswas, Yun-Hsin Liu, Javier Herrero

|Sep 25, 2024
Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade.

Panayiotis Anastasiou, Christopher Moore, Sareena Rana

|Apr 18, 2024
CRISPR-Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung Cancer.

Jesse Boumelha, Andrea de Castro, Nourdine Bah

|Sep 26, 2022
RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma.

Philip East, Gavin P Kelly, Dhruva Biswas

Pageof 2

Frequent Collaborators

6 joint publications

Julian Downward

5 joint publications

Philip East

4 joint publications

Christopher Moore

4 joint publications

Miriam Molina-Arcas